Fig. 3From: Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancerNRDP1 immunohistochemistry. a Positive control (testis, cells in seminiferous ducts), b Positive control (mononuclear blood cells), c Absent NRDP1 expression (breast carcinoma), d Cytoplasmic NRDP1 expression (breast carcinoma), e and f Nuclear NRDP1 expression (breast carcinoma). Mayer's Hematoxylin used as a counterstainBack to article page